scholarly article | Q13442814 |
P2093 | author name string | Beth B Murinson | |
Joseph B Guarnaccia | |||
P2860 | cites work | Expression of amphiphysin I, an autoantigen of paraneoplastic neurological syndromes, in breast cancer | Q24654263 |
The synaptic vesicle-associated protein amphiphysin is the 128-kD autoantigen of Stiff-Man syndrome with breast cancer | Q24680318 | ||
Autoimmunity to gephyrin in Stiff-Man syndrome | Q28145724 | ||
The stiff-person syndrome: an autoimmune disorder affecting neurotransmission of gamma-aminobutyric acid | Q31406782 | ||
The stiff man and stiff man plus syndromes | Q33719054 | ||
Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus | Q34172103 | ||
Stiff-man syndrome updated | Q34674686 | ||
Antiamphiphysin-positive stiff-person syndrome associated with small cell lung cancer | Q39753843 | ||
Antibodies against glutamic acid decarboxylase: prevalence in neurological diseases | Q42206137 | ||
Amphiphysin autoimmunity: paraneoplastic accompaniments | Q45130801 | ||
Markedly elevated GAD antibodies in SPS: effects of age and illness duration | Q45185832 | ||
Atypical stiff-person syndrome with spinal MRI findings, amphiphysin autoantibodies, and immunosuppression | Q47801402 | ||
Antiamphiphysin antibodies are associated with various paraneoplastic neurological syndromes and tumors | Q48280487 | ||
Autoantibodies to a 128-kd synaptic protein in three women with the stiff-man syndrome and breast cancer | Q48330778 | ||
Paraneoplastic stiff-person syndrome: passive transfer to rats by means of IgG antibodies to amphiphysin | Q48924908 | ||
Stiff-Person Syndrome | Q54165707 | ||
High-Dose Intravenous Immune Globulin for Stiff-Person Syndrome | Q59649757 | ||
Stiff-man syndrome in a woman with breast cancer: an uncommon central nervous system paraneoplastic syndrome | Q74093678 | ||
P433 | issue | 24 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | antibody | Q79460 |
stiff-person syndrome | Q1235785 | ||
rare disease | Q929833 | ||
P304 | page(s) | 1955-1958 | |
P577 | publication date | 2008-10-29 | |
P1433 | published in | Neurology | Q1161692 |
P1476 | title | Stiff-person syndrome with amphiphysin antibodies: distinctive features of a rare disease. | |
P478 | volume | 71 |
Q55401910 | AMPH-1 is critical for breast cancer progression. |
Q33600142 | Advances in Autoimmune Epilepsy Associated with Antibodies, Their Potential Pathogenic Molecular Mechanisms, and Current Recommended Immunotherapies |
Q41977560 | Anti-glutamic Acid decarboxylase antibody-associated ataxia as an extrahepatic autoimmune manifestation of hepatitis C infection: a case report |
Q26780374 | Antibodies as Mediators of Brain Pathology |
Q39180685 | Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of the Central Nervous System |
Q39102143 | Autoimmune Movement Disorders: a Clinical and Laboratory Approach. |
Q28264405 | Autoimmune stiff person syndrome and related myelopathies: understanding of electrophysiological and immunological processes |
Q35947819 | Central nervous system neuronal surface antibody associated syndromes: review and guidelines for recognition |
Q26753841 | Clinical Spectrum of Stiff Person Syndrome: A Review of Recent Reports |
Q38188019 | Efficacy of therapeutic plasma exchange for treatment of stiff-person syndrome |
Q95840283 | GAD antibodies in neurological disorders - insights and challenges |
Q51210635 | GAD65 neurological autoimmunity. |
Q57254069 | Immune-Mediated Paraneoplastic Neurologic Disorders: An Overview |
Q59812985 | Management of Autoimmune Encephalitis: An Observational Monocentric Study of 38 Patients |
Q34272611 | Movement disorders in autoimmune diseases |
Q36993609 | Movement disorders in paraneoplastic and autoimmune disease. |
Q47623969 | Movement disorders with neuronal antibodies: syndromic approach, genetic parallels and pathophysiology |
Q92407350 | Neuronal Antibodies and Associated Syndromes |
Q37032830 | Neuronal autoantigens--pathogenesis, associated disorders and antibody testing |
Q28072253 | Neuronal central nervous system syndromes probably mediated by autoantibodies |
Q37459730 | Novel autoimmune response in a tauopathy mouse model |
Q52817532 | Ophthalmoplegia heralding the onset of anti-amphiphysin related paraneoplastic stiff person syndrome. |
Q37936924 | Paraneoplastic encephalomyelopathies: pathology and mechanisms |
Q37514505 | Paraneoplastic movement disorders. |
Q28077708 | Paraneoplastic neurological complications of breast cancer |
Q92341942 | Paraneoplastic neurological syndromes in the era of immune-checkpoint inhibitors |
Q58568103 | Pragmatic Treatment of Stiff Person Spectrum Disorders |
Q36098256 | Protein Citrullination: A Proposed Mechanism for Pathology in Traumatic Brain Injury |
Q26768678 | Recent Advances and Review on Treatment of Stiff Person Syndrome in Adults and Pediatric Patients |
Q42437564 | Role of BAFF in Opsoclonus-Myoclonus syndrome, a bridge between cancer and autoimmunity |
Q57255969 | Screening for Tumours in Paraneoplastic Syndromes |
Q34911466 | Screening for tumours in paraneoplastic syndromes: report of an EFNS task force. |
Q26770774 | Spinal-generated movement disorders: a clinical review |
Q42540446 | Stiff Person Syndrome: A Rare Neurological Disorder, Heterogeneous in Clinical Presentation and Not Easy to Treat. |
Q51581002 | Stiff-person syndrome presenting as eating disorder: a case report. |
Q38289691 | Stiff-person syndrome: insights into a complex autoimmune disorder |
Q26769676 | The Diagnosis and Treatment of Autoimmune Encephalitis |
Q28295552 | The immunological basis for treatment of stiff person syndrome |
Q49992413 | Treating Immune-Related Epilepsy |
Q42907014 | Treatment of paraneoplastic neurologic disorders |
Q58555813 | Updates in the Diagnosis and Treatment of Paraneoplastic Neurologic Syndromes |
Q86560972 | [Stiff man syndrome and variants] |
Search more.